Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Discuss this option with your doctor
The appropriate diluent depends on the peptide being studied and the intended experimental design
Retatrutide (development code LY-3437943) is a synthetic peptide developed by Eli Lilly and Company designed to act simultaneously on three hormone-receptor pathways: GLP-1 (glucagonlike peptide-1) GIP (glucosedependent insulinotropic polypeptide) Glucagon receptor (GCG) nejm.org Put simply: it takes the mechanism of todays weight-loss injections and adds an extra dimension of hormonal stimulation, with the aim of significantly greater weight-loss outcomes
Cel Res 1866 (7), 11511161
Fansa, Sima MD2
US$ 22.83
US$ 24.12
US$ 22.29
US$ 25.88
US$ 22.20
US$ 23.62
